{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:06:08Z","timestamp":1777982768907,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.aca.2026.345214","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:49:57Z","timestamp":1770479397000},"page":"345214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Microscale native size exclusion chromatography high resolution mass spectrometry for the determination of the chelator-to-antibody ratio of immunoconjugates"],"prefix":"10.1016","volume":"1395","author":[{"given":"Annika A.M.","family":"van der Zon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4339-1496","authenticated-orcid":false,"given":"Bram","family":"Weijers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7068-8152","authenticated-orcid":false,"given":"Danielle J.","family":"Vugts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-7341","authenticated-orcid":false,"given":"Andrea F.G.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2026.345214_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41568-023-00576-4","article-title":"Advances in PET imaging of cancer","volume":"23","author":"Schwenck","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.aca.2026.345214_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108115","article-title":"Unveiling the chemistry of antibody conjugation for enhanced PET imaging: current trends and future directions","volume":"155","author":"Saccullo","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061454","article-title":"Radiolabeled antibodies for cancer imaging and therapy","volume":"14","author":"Parakh","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.aca.2026.345214_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ddtec.2018.10.002","article-title":"Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals","volume":"30","author":"Morais","year":"2018","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.aca.2026.345214_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/antib13020030","article-title":"Enhanced characterization of lysine-linked antibody drug conjugates enabled by middle-down mass spectrometry and higher-energy collisional dissociation-triggered electron-transfer\/higher-energy collisional dissociation and ultraviolet photodissociation","volume":"13","author":"Watts","year":"2024","journal-title":"Antibodies"},{"key":"10.1016\/j.aca.2026.345214_bib6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1021\/bc5004982","article-title":"Site-specific antibody\u2013drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development","volume":"26","author":"Agarwal","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib7","author":"Harsini"},{"key":"10.1016\/j.aca.2026.345214_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s41181-024-00258-y","article-title":"Good practices for 89Zr radiopharmaceutical production and quality control","volume":"9","author":"Wuensche","year":"2024","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nucmedbio.2021.08.001","article-title":"Comparison of analytical methods for antibody conjugates with application in nuclear imaging \u2013 report from the trenches","volume":"102\u2013103","author":"Feiner","year":"2021","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.aca.2026.345214_bib10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0003-2697(84)90517-7","article-title":"Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions","volume":"142","author":"Meares","year":"1984","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.aca.2026.345214_bib11","first-page":"1271","article-title":"89Zr Immuno-PET: comprehensive procedures for the production of 89Zr-Labeled monoclonal antibodies","volume":"44","author":"Verel","year":"2003","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.aca.2026.345214_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","article-title":"Exploring the next generation of antibody\u2013drug conjugates","volume":"21","author":"Tsuchikama","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.aca.2026.345214_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116621","article-title":"Analytical tools for antibody\u2013drug conjugates: from in vitro to in vivo","volume":"152","author":"Liu","year":"2022","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.chroma.2018.12.020","article-title":"Is hydrophobic interaction chromatography the Most suitable technique to characterize site-specific antibody-drug conjugates?","volume":"1586","author":"D'Atri","year":"2019","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2026.345214_bib15","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1021\/acs.analchem.7b02110","article-title":"An online four-dimensional HIC\u00d7SEC-IM\u00d7MS methodology for proof-of-concept characterization of antibody drug conjugates","volume":"90","author":"Ehkirch","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2446304","article-title":"Online native hydrophobic interaction chromatography-mass spectrometry of antibody-drug conjugates","volume":"17","author":"Kempen","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.aca.2026.345214_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpha.2020.05.008","article-title":"Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates","volume":"10","author":"Zhu","year":"2020","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.aca.2026.345214_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jpba.2017.01.013","article-title":"Separation of antibody drug conjugate species by RPLC: a generic method development approach","volume":"137","author":"Fekete","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345214_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpba.2017.06.022","article-title":"Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates","volume":"147","author":"Bob\u00e1ly","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345214_bib20","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3390\/ph14060498","article-title":"State-of-the-Art native mass spectrometry and ion mobility methods to monitor homogeneous site-specific antibody-drug conjugates synthesis","volume":"14","author":"Desligni\u00e8re","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.aca.2026.345214_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/19420862.2018.1433973","article-title":"Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry","volume":"10","author":"Friese","year":"2018","journal-title":"mAbs"},{"key":"10.1016\/j.aca.2026.345214_bib22","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1021\/acs.analchem.4c06661","article-title":"Simultaneous analysis of the drug-to-antibody ratio, free-drug-related impurities, and purity of antibody\u2013drug conjugates based on size exclusion chromatography","volume":"97","author":"Song","year":"2025","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124007","article-title":"Automated high-throughput buffer exchange platform enhances rapid flow analysis of antibody drug conjugates by high resolution mass spectrometry","volume":"1235","author":"Yang","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345214_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2023.341324","article-title":"Micro-flow size-exclusion chromatography for enhanced native mass spectrometry of proteins and protein complexes","volume":"1266","author":"Ventouri","year":"2023","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.aca.2026.345214_bib25","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00259-020-05002-7","article-title":"Head-to-head comparison of DFO\u2217 and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET","volume":"48","author":"Chomet","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.aca.2026.345214_bib26","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/acs.analchem.5b00140","article-title":"Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles","volume":"87","author":"Marty","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2019.110753","article-title":"The solution thermodynamic stability of desferrioxamine B (DFO) with Zr(IV)","volume":"198","author":"Toporivska","year":"2019","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.aca.2026.345214_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.chroma.2018.01.039","article-title":"Extending the limits of size exclusion chromatography: simultaneous separation of free payloads and related species from antibody drug conjugates and their aggregates","volume":"1539","author":"Goyon","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2026.345214_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2022.463262","article-title":"Investigating the secondary interactions of packing materials for size-exclusion chromatography of therapeutic proteins","volume":"1676","author":"Fekete","year":"2022","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.aca.2026.345214_bib30","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchromb.2018.06.029","article-title":"Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins","volume":"1092","author":"Goyon","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345214_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jpba.2016.09.031","article-title":"Comprehensive study on the effects of sodium and potassium additives in size exclusion chromatographic separations of protein biopharmaceuticals","volume":"144","author":"Goyon","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345214_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114287","article-title":"Simultaneous monitoring of multiple attributes of pyrrolobenzodiazepine antibody-drug conjugates by size exclusion chromatography \u2013 high resolution mass spectrometry","volume":"205","author":"F\u00fcssl","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.aca.2026.345214_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124167","article-title":"A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates","volume":"1241","author":"Wu","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.aca.2026.345214_bib34","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1682895","article-title":"Native size-exclusion chromatography-mass spectrometry: suitability for antibody\u2013drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels","volume":"12","author":"Jones","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.aca.2026.345214_bib35","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1021\/acs.analchem.9b02192","article-title":"Comparison of analytical methods for antibody\u2013drug conjugates produced by chemical site-specific conjugation: first-generation AJICAP","volume":"91","author":"Matsuda","year":"2019","journal-title":"Anal. Chem."},{"key":"10.1016\/j.aca.2026.345214_bib36","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/s41596-019-0281-0","article-title":"Rapid online buffer exchange for screening of proteins, protein complexes and cell lysates by native mass spectrometry","volume":"15","author":"VanAernum","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.aca.2026.345214_bib37","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/glycob\/cwz045","article-title":"Updates to the symbol nomenclature for glycans guidelines","volume":"29","author":"Neelamegham","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.aca.2026.345214_bib38","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/antib9030046","article-title":"Investigating the impact of sample preparation on mass spectrometry-based drug-to-antibody ratio determination for Cysteine- and lysine-linked antibody\u2013drug conjugates","volume":"9","author":"K\u00e4llsten","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.aca.2026.345214_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijms.2020.116502","article-title":"Pushing the limits of native MS: Online SEC-native MS for structural biology applications","volume":"461","author":"Desligni\u00e8re","year":"2021","journal-title":"Int. J. Mass Spectrom."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026001649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267026001649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T13:09:11Z","timestamp":1772197751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267026001649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"alternative-id":["S0003267026001649"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2026.345214","relation":{"has-preprint":[{"id-type":"doi","id":"10.26434\/chemrxiv-2025-vncjq","asserted-by":"object"}]},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microscale native size exclusion chromatography high resolution mass spectrometry for the determination of the chelator-to-antibody ratio of immunoconjugates","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2026.345214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"345214"}}